Loading…
21 of 111 unique stocks in common · Jaccard: 18.9%
A weighted portfolio overlap of 38.47% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹38.47 is allocated to the exact same companies at the same relative proportions. The schemes share 21 common holdings.
The largest overlapping asset in their portfolios is ICICI Bank, which commands a weight of 6.44% in HDFC Value Fund and 9.03% in ICICI Prudential Value Fund. Holding both schemes increases your concentration in ICICI Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in ICICI |
|---|---|---|
| ICICI BankBanks | 6.44% | 9.03% |
| HDFC BankBanks | 5.26% | 9.12% |
| Axis BankBanks | 4.27% | 2.99% |
| InfosysIT - Software | 2.70% | 6.17% |
| NTPCPower | 2.65% | 2.43% |
| Reliance IndustriesPetroleum Products | 2.26% | 4.82% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.21% | 4.72% |
| SBI Life Insurance CompanyInsurance | 2.13% | 2.42% |
| State Bank of IndiaBanks | 3.49% | 1.96% |
| Bharti AirtelTelecom - Services | 3.25% | 1.93% |
| Larsen & ToubroConstruction | 2.93% | 1.88% |
| Maruti Suzuki IndiaAutomobiles | 1.29% | 3.37% |
| Ultratech CementCement & Cement Products | 1.11% | 1.16% |
| Hindustan UnileverDiversified FMCG | 1.01% | 2.98% |
| Hyundai Motor IndiaAutomobiles | 0.66% | 1.41% |
| MphasisIT - Software | 0.62% | 0.56% |
| Godrej Consumer ProductsPersonal Products | 1.29% | 0.45% |
| HCL TechnologiesIT - Software | 1.46% | 0.35% |
| Bharat Petroleum CorporationPetroleum Products | 0.82% | 0.33% |
| Canara HSBC Life Insurance CoInsurance | 0.66% | 0.28% |
| LupinPharmaceuticals & Biotechnology | 1.47% | 0.25% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.